Mini-review: efficacy of lytic bacteriophages on multispecies biofilms

Biofouling
Legesse Geredew KifelewPeter Speck

Abstract

There is potential for phages to prevent and control bacterial biofilms, but few studies have examined the effect of phages on the multispecies biofilms that characterize most bacterial infections. This paper reviews the mechanism of action of phages, the evidence supporting the view that phage therapy will be effective against bacterial targets and the opposite viewpoint, phage application approaches, and the comparative advantage of phage therapy in multispecies biofilms. The few reports measuring the actions of lytic phages against multispecies biofilms are also reviewed. The authors are cautiously optimistic about the application of phages against their targets when in multispecies biofilms because some lysis mechanisms do not require species specificity.

References

Oct 1, 1979·Canadian Journal of Microbiology·M L SaxelinV Sundman
Apr 1, 1975·Journal of Virology·W BesslerS Stirm
Jan 1, 1983·Journal of Virology·B KwiatkowskiS Stirm
Aug 1, 1982·Journal of Virology·B KwiatkowskiS Stirm
Oct 6, 2000·Annual Review of Microbiology·G O'TooleR Kolter
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·D NelsonVincent A Fischetti
Aug 30, 2002·Applied and Environmental Microbiology·Hélène DeveauSylvain Moineau
Feb 25, 2003·Trends in Microbiology·Alexander H RickardPauline S Handley
Oct 24, 2003·Current Opinion in Microbiology·Steven J Projan
Nov 19, 2003·Biofouling·David G Allison
Apr 6, 2004·FEMS Microbiology Letters·I W SutherlandKaren Tait
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Quintin F WillsJ S Soothill
Sep 10, 2005·Applied and Environmental Microbiology·W R Harcombe, J J Bull
Nov 30, 2005·Comptes rendus biologies·P Lacroix-GueuMarie-Pierre Fontaine-Aupart
Jun 20, 2006·Burns : Journal of the International Society for Burn Injuries·J A Sivera MarzaT A Collyns
Mar 28, 2007·Antimicrobial Agents and Chemotherapy·Catherine S McVayJoe A Fralick
Jun 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Timothy K Lu, James J Collins
Dec 21, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Z M TheinL P Smaranayake
Feb 5, 2008·Applied and Environmental Microbiology·R BriandetM-P Fontaine-Aupart
May 2, 2009·Trends in Ecology & Evolution·Max Teplitski, Kim Ritchie
Jun 11, 2009·Drug Discovery Today·John N Housby, Nicholas H Mann
Jan 1, 2009·Current Pharmaceutical Biotechnology·Elizabeth KutterStephen T Abedon
Mar 30, 2010·Nature Reviews. Microbiology·Simon J LabrieSylvain Moineau
Jun 10, 2010·FEMS Immunology and Medical Microbiology·Louise CarsonBrendan F Gilmore
Aug 3, 2010·Nature Reviews. Microbiology·Hans-Curt Flemming, Jost Wingender
Sep 8, 2010·Journal of Microbiological Methods·Tom Coenye, Hans J Nelis
Nov 11, 2010·Pharmaceutical Research·Jean-Paul PirnayRevaz Adamia
Dec 7, 2010·Applied and Environmental Microbiology·Matthew K KayGary M Aron
Dec 1, 1998·Journal of Applied Microbiology·L C SkillmanM V Jones
May 4, 2011·Applied Microbiology and Biotechnology·Esther KarunakaranCatherine A Biggs
Nov 8, 2011·Biotechnology Progress·Jun HuYasunori Tanji
Jan 11, 2012·Clinical Microbiology Reviews·Brian M PetersMark E Shirtliff
Feb 23, 2012·Journal of Applied Microbiology·J WoodsGarth A James
Apr 25, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Gilbert VerbekenIsabelle Huys
Aug 29, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R WolcottS J Cutler
Jan 18, 2013·The Journal of Bone and Joint Surgery. American Volume·Cengiz YilmazMehmet Gozlugol
Jan 30, 2013·Plastic and Reconstructive Surgery·Akhil K SethSeok J Hong
Feb 21, 2013·MBio·Nina Molin Høyland-KroghsboSine Lo Svenningsen
Apr 3, 2013·Cold Spring Harbor Perspectives in Medicine·Maria KostakiotiScott J Hultgren
Apr 13, 2013·Nature·Peter Speck
Jun 7, 2013·Bacteriophage·Damien Maura, Laurent Debarbieux
Sep 18, 2013·Antimicrobial Agents and Chemotherapy·Marine HenryLaurent Debarbieux
Dec 20, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jianlong YanJianping Xie
Feb 13, 2014·Journal of Infection in Developing Countries·Zhabiz GolkarDonald Gene Pace
Feb 15, 2014·Advances in Wound Care·Ge ZhaoJohn E Olerud
Apr 11, 2014·American Journal of Rhinology & Allergy·Amanda DrillingPeter-John Wormald
Jun 22, 2014·Applied and Environmental Microbiology·Ruoting Pei, Gisella R Lamas-Samanamud
Aug 15, 2014·Health Communication·Rachel A SmithAndrew F Read
Sep 6, 2014·Current Pharmaceutical Design·Benjamin K Chan, Stephen T Abedon
Jan 15, 2015·Pharmaceutical Research·Jean-Paul PirnayGuy Van den Eede
Mar 3, 2015·Biotechnology and Bioengineering·Ananda Shankar BhattacharjeeRamesh Goel
Mar 10, 2015·Applied and Environmental Microbiology·Diana GutiérrezPilar García
May 23, 2015·Future Microbiology·Elizabeth Martin KutterStephen T Abedon
Sep 4, 2015·Virology·Zachary J Storms, Dominic Sauvageau
Jan 20, 2016·Science·Ry Young, Jason J Gill
Feb 21, 2016·FEMS Microbiology Reviews·Hans P SteenackersJozef Vanderleyden
Apr 30, 2016·The Journal of Biological Chemistry·Norma M Allewell
May 14, 2016·Journal of Molecular Biology·Wei Hong TayKimberly A Kline
Jul 5, 2016·Frontiers in Microbiology·Diana GutiérrezPilar García
Dec 2, 2016·Journal of Medical Microbiology·Kavitha ShettigarThokur Sreepathy Murali

Related Concepts

Bacteriophages
Microbial Biofilms
Bacterial Infections
Bacteriophages
Lysis
Microbial Biofilms
Application Procedure
Lytic Virus
Opposite
Species

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

© 2021 Meta ULC. All rights reserved